ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Drivers...

σε πρόσθεσε στο Health

2025-09-18 09:31:29 - Μετάφραση

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Drivers and Opportunities

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Size The ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is an emerging, clinically important segment of oncology diagnostics driven by the need to detect acquired resistance to endocrine therapy in hormone-receptor (HR+) metastatic breast cancer. Market estimates place the diagnostics segment at roughly US$ 60–65 million...

0 Σχόλια 0 Μοιράστηκε 50 Views 0 Προεπισκόπηση